(Q79792868)
Statements
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN) (English)
Robert H Knopp
Johan G Smilde
Stuart J Pocock